QIAGEN N.V. Interest Expense 2011-2026 | QGEN

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense QIAGEN N.V.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-6.65 M	-739 K	-5.71 M	6.74 M	54.5 M	71.3 M	74.2 M	67.3 M	49.7 M	39 M	37.4 M	39.3 M	30.9 M	23.5 M	25.4 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
74.2 M	-6.65 M	33.7 M

Interest Expense of other stocks in the Diagnostics research industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Castle Biosciences CSTL	144 K	$ 20.15	-1.9 %	$ 584 M	USA
Centogene N.V. CNTG	8.42 M	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	4.19 M	-	-	$ 1.31 B	USA
Guardant Health GH	-10.5 M	$ 118.95	0.8 %	$ 14.9 B	USA
Fulgent Genetics FLGT	153 K	$ 17.11	-1.55 %	$ 517 M	USA
ICON Public Limited Company ICLR	337 M	$ 116.78	0.18 %	$ 9.63 B	Irlanda
Agilent Technologies A	81 M	$ 114.96	0.15 %	$ 34.9 B	USA
Celcuity CELC	5.33 M	$ 138.23	-3.02 %	$ 6.46 B	USA
Co-Diagnostics CODX	106 K	$ 5.07	36.66 %	$ 6.74 M	USA
Akumin AKU	118 M	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	1.81 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-595 K	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	316 K	-	-13.05 %	$ 7.29 M	USA
CareDx, Inc CDNA	524 K	$ 21.63	0.28 %	$ 1.15 B	USA
Chembio Diagnostics CEMI	2.94 K	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	13 K	-	-	$ 9.42 M	Israel
HTG Molecular Diagnostics HTGM	857 K	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	-292 M	$ 144.41	-0.29 %	$ 23 B	USA
Interpace Biosciences IDXG	-394 K	$ 1.82	1.11 %	$ 8.05 M	USA
Lantheus Holdings LNTH	31.3 M	$ 103.0	9.03 %	$ 6.95 B	USA
Medpace Holdings MEDP	-5.34 M	$ 432.8	0.63 %	$ 12.5 B	USA
Global Cord Blood Corporation CO	6.27 M	-	-	$ 399 M	China
Mettler-Toledo International MTD	68.5 M	$ 1 103.09	1.16 %	$ 22.7 B	Schweiz
Genetic Technologies Limited GENE	17.6 K	-	-	$ 7.1 B	Australia
DermTech DMTK	-355 K	-	-11.32 %	$ 2.94 M	USA
Charles River Laboratories International CRL	-22.6 M	$ 160.3	0.91 %	$ 7.95 B	USA
Personalis PSNL	205 K	$ 8.47	2.67 %	$ 756 M	USA
Enzo Biochem ENZ	494 K	-	-8.98 %	$ 14.8 K	USA
NeoGenomics NEO	296 K	$ 9.23	1.32 %	$ 1.18 B	USA
Exact Sciences Corporation EXAS	18.6 M	-	-	$ 19.8 B	USA
National Research Corporation NRC	-95 K	$ 19.08	0.21 %	$ 427 M	USA
Natera NTRA	9.32 M	$ 203.19	-0.25 %	$ 20 B	USA
Myriad Genetics MYGN	800 K	$ 3.82	-2.3 %	$ 354 M	USA
Koninklijke Philips N.V. PHG	288 M	$ 26.95	-0.74 %	$ 25.6 B	Niderland
Senseonics Holdings SENS	-23 K	$ 6.34	2.92 %	$ 265 M	USA
Twist Bioscience Corporation TWST	-903 K	$ 60.57	2.95 %	$ 3.62 B	USA
Soleno Therapeutics SLNO	2.58 M	-	-	$ 2.69 B	USA
Biomerica BMRA	367	$ 2.49	2.05 %	$ 5.72 M	USA
Laboratory Corporation of America Holdings LH	224 M	$ 259.93	1.63 %	$ 21.6 B	USA
Thermo Fisher Scientific TMO	-12 M	$ 448.28	-0.24 %	$ 169 B	USA
Trinity Biotech plc TRIB	6.75 M	$ 0.6	-3.7 %	$ 216 M	Irlanda
Motus GI Holdings MOTS	211	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	38.1 M	$ 8.9	0.45 %	$ 1.93 B	USA
Waters Corporation WAT	14.3 M	$ 342.37	0.4 %	$ 20.4 B	USA
Quest Diagnostics Incorporated DGX	26 M	$ 195.21	0.72 %	$ 21.7 B	USA